Skip to main navigation Skip to search Skip to main content

ELII: Preclinical Development of Novel Reickettsiosis Therapeutics Targeting EPAC1

Project: Research project

Project Details

StatusFinished
Effective start/end date4/10/14 → 3/31/17

Funding

  • University of Texas Health Science Center - Houston ( Award #5R01AI11146405): $2,372,242.00